Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA-directed RNA polymerase II subunit J3 (POLR2J3) is one of three human subunits forming the RPB11 protein family within RNA polymerase II, an essential multi-protein enzyme complex responsible for transcription of protein-coding genes and various functional RNAs in eukaryotes. The gene produces multiple, alternatively spliced transcripts but its protein-coding status in vivo remains uncertain as many variants are candidates for nonsense-mediated decay. In the RNA polymerase II complex, POLR2J3 participates in the core element assembly and may contribute to complex stability and function but is not individually implicated in disease or targeted by drugs. Its main function is as part of the basal RNA polymerase II machinery, enabling the transcription of DNA into RNA.
Not applicable; no drug mechanisms are established for this subunit.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA-directed RNA polymerase II subunit J3 (POLR2J3).